Good Neighbor Pharmacy® Named #1 in Customer Satisfaction with Chain Drug Store Pharmacies by J.D. Power for 8th Consecutive Year

Good Neighbor Pharmacy received top scores in all study dimensions, including ‘level of trust with pharmacy’

Good Neighbor Pharmacy (GNP), a national franchise for independent pharmacies offered through Cencora, announced that it has been ranked “#1 in Customer Satisfaction with Chain Drug Store Pharmacies” in the J.D. Power 2024 U.S. Pharmacy Study^SM. This is the 13^th time that Good Neighbor Pharmacy has earned this recognition in the last 15 years and marks the network’s eighth consecutive win.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20240731497360/en/

“I’d like to extend my sincere congratulations to our Good Neighbor Pharmacy members on receiving this prestigious recognition from J.D. Power for the eighth consecutive year,” said Jenni Zilka, SVP, Community & Specialty Pharmacy and President of Good Neighbor Pharmacy. “This feat reflects our member pharmacies’ unwavering dedication to putting their patients first and delivering exceptional care every day. It is a privilege to stand alongside them as they demonstrate the power of pharmacies as accessible destinations for high-touch, high-quality care, and an honor to say that no one does it better than the Good Neighbor Pharmacy network.”

The J.D. Power 2024 U.S. Pharmacy Study implements a modular approach in which respondents complete a core set of questions addressing seven dimensions that represent distinct parts of the customer experience. In addition to receiving #1 in Chain Drug Store Pharmacy Customer Satisfaction overall, Good Neighbor Pharmacy ranked #1 across all seven core dimensions, specifically:

• Pharmacy offerings meet my needs
• Resolving problems or complaints
• Able to get prescriptions how/when I want
• Digital channels – website, mobile app, text
• People
• Helping to save me time or money
• My level of trust with pharmacy

“This recognition truly belongs to our Good Neighbor Pharmacy members, as the results of J.D. Power’s study are a testament to their commitment to serving their communities,” said Tim Cernohous, SVP & President, Community, Retail and Long-Term Care Pharmacy at Cencora. “As patients seek out pharmacies for care services beyond dispensing medications, pharmacists are navigating the opportunities and challenges that come with those expectations. Our Good Neighbor Pharmacy members have a deep reach into, and close relationships with, their communities. This, combined with their clinical background, has allowed them to organically step into an expanded role to meet the growing needs of their patients. We are honored to work side by side with our Good Neighbor Pharmacy members, ensuring that they have the resources needed to continue serving their communities while paving the path of independent pharmacy forward.”

The J.D. Power U.S. Pharmacy Study, now in its 15th year, is a syndicated benchmarking study profiling the experiences of customers from the largest pharmacies in the United States. The 2024 study is based on responses from 13,505 U.S. pharmacy customers who filled a prescription in the last 12 months prior to the survey period of September 2023 to May 2024.

To learn more about Good Neighbor Pharmacy, visit https://www.wearegnp.com/. Learn more about J.D. Power at http://jdpower.com/awards.

About Cencora

Cencora is a leading global pharmaceutical solutions organization centered on improving the lives of people and animals around the world. We partner with pharmaceutical innovators across the value chain to facilitate and optimize market access to therapies. Care providers depend on us for the secure, reliable delivery of pharmaceuticals, healthcare products, and solutions. Our 46,000+ worldwide team members contribute to positive health outcomes through the power of our purpose: We are united in our responsibility to create healthier futures. Cencora is ranked #10 on the Fortune 500 and #24 on the Global Fortune 500 with more than $250 billion in annual revenue. Learn more at investor.cencora.com.

View source version on businesswire.com: https://www.businesswire.com/news/home/20240731497360/en/